• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长非编码 RNA 对肥胖相关的肝脏脂肪生成和非酒精性脂肪性肝病发病机制的调控作用。

Long noncoding RNA licensing of obesity-linked hepatic lipogenesis and NAFLD pathogenesis.

机构信息

Life Sciences Institute and Department of Cell & Developmental Biology, University of Michigan Medical Center, Ann Arbor, MI, 48109, USA.

Ministry of Education Key Laboratory of Metabolism and Molecular Medicine, Department of Endocrinology and Metabolism, Zhongshan Hospital, Fudan University, Shanghai, 200030, China.

出版信息

Nat Commun. 2018 Jul 30;9(1):2986. doi: 10.1038/s41467-018-05383-2.

DOI:10.1038/s41467-018-05383-2
PMID:30061575
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6065308/
Abstract

Hepatic lipogenesis is aberrantly induced in nonalcoholic fatty liver disease (NAFLD) via activation of the LXR-SREBP1c pathway. To date, a number of protein factors impinging on the transcriptional activity of LXR and SREBP1c have been elucidated. However, whether this regulatory axis interfaces with long noncoding RNAs (lncRNAs) remains largely unexplored. Here we show that hepatic expression of the lncRNA Blnc1 is strongly elevated in obesity and NAFLD in mice. Blnc1 is required for the induction of SREBP1c and hepatic lipogenic genes in response to LXR activation. Liver-specific inactivation of Blnc1 abrogates high-fat diet-induced hepatic steatosis and insulin resistance and protects mice from diet-induced nonalcoholic steatohepatitis. Proteomic analysis of the Blnc1 ribonucleoprotein complex identified EDF1 as a component of the LXR transcriptional complex that acts in concert with Blnc1 to activate the lipogenic gene program. These findings illustrate a lncRNA transcriptional checkpoint that licenses excess hepatic lipogenesis to exacerbate insulin resistance and NAFLD.

摘要

肝脂肪生成在非酒精性脂肪性肝病 (NAFLD) 中通过 LXR-SREBP1c 途径的激活而异常诱导。迄今为止,已经阐明了许多影响 LXR 和 SREBP1c 转录活性的蛋白质因子。然而,该调节轴是否与长链非编码 RNA (lncRNA) 相互作用在很大程度上仍未得到探索。在这里,我们发现 lncRNA Blnc1 在肥胖和 NAFLD 小鼠中的肝脏表达强烈升高。Blnc1 是 LXR 激活后诱导 SREBP1c 和肝脏脂肪生成基因所必需的。Blnc1 的肝特异性失活可消除高脂肪饮食诱导的肝脂肪变性和胰岛素抵抗,并保护小鼠免受饮食诱导的非酒精性脂肪性肝炎。Blnc1 核糖核蛋白复合物的蛋白质组学分析鉴定出 EDF1 是 LXR 转录复合物的一个组成部分,它与 Blnc1 协同作用激活脂肪生成基因程序。这些发现说明了 lncRNA 转录检查点,该检查点许可过度的肝脂肪生成以加重胰岛素抵抗和 NAFLD。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/131d/6065308/557db3d9022b/41467_2018_5383_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/131d/6065308/62690c221bf6/41467_2018_5383_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/131d/6065308/b8148cfc856f/41467_2018_5383_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/131d/6065308/452c59c743e4/41467_2018_5383_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/131d/6065308/338d2a5243c9/41467_2018_5383_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/131d/6065308/321073117f83/41467_2018_5383_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/131d/6065308/70e4424b4455/41467_2018_5383_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/131d/6065308/d16f41b41e3b/41467_2018_5383_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/131d/6065308/2cce3159f4a9/41467_2018_5383_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/131d/6065308/e4768a1569f6/41467_2018_5383_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/131d/6065308/557db3d9022b/41467_2018_5383_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/131d/6065308/62690c221bf6/41467_2018_5383_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/131d/6065308/b8148cfc856f/41467_2018_5383_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/131d/6065308/452c59c743e4/41467_2018_5383_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/131d/6065308/338d2a5243c9/41467_2018_5383_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/131d/6065308/321073117f83/41467_2018_5383_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/131d/6065308/70e4424b4455/41467_2018_5383_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/131d/6065308/d16f41b41e3b/41467_2018_5383_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/131d/6065308/2cce3159f4a9/41467_2018_5383_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/131d/6065308/e4768a1569f6/41467_2018_5383_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/131d/6065308/557db3d9022b/41467_2018_5383_Fig10_HTML.jpg

相似文献

1
Long noncoding RNA licensing of obesity-linked hepatic lipogenesis and NAFLD pathogenesis.长非编码 RNA 对肥胖相关的肝脏脂肪生成和非酒精性脂肪性肝病发病机制的调控作用。
Nat Commun. 2018 Jul 30;9(1):2986. doi: 10.1038/s41467-018-05383-2.
2
Regulation of hepatic lipogenesis by asymmetric arginine methylation.不对称精氨酸甲基化调控肝脂生成。
Metabolism. 2024 Aug;157:155938. doi: 10.1016/j.metabol.2024.155938. Epub 2024 May 23.
3
Thyroid hormone-responsive SPOT 14 homolog promotes hepatic lipogenesis, and its expression is regulated by liver X receptor α through a sterol regulatory element-binding protein 1c-dependent mechanism in mice.甲状腺激素反应性 SPOT14 同源物促进肝内脂质生成,其表达受肝 X 受体 α 通过固醇调节元件结合蛋白 1c 依赖性机制在小鼠中调控。
Hepatology. 2013 Aug;58(2):617-28. doi: 10.1002/hep.26272. Epub 2013 Jul 2.
4
Long noncoding RNA lncARSR promotes hepatic lipogenesis via Akt/SREBP-1c pathway and contributes to the pathogenesis of nonalcoholic steatohepatitis.长链非编码RNA lncARSR通过Akt/SREBP-1c信号通路促进肝脏脂肪生成,并参与非酒精性脂肪性肝炎的发病机制。
Biochem Biophys Res Commun. 2018 Apr 30;499(1):66-70. doi: 10.1016/j.bbrc.2018.03.127. Epub 2018 Mar 20.
5
Long Noncoding RNA lncSHGL Recruits hnRNPA1 to Suppress Hepatic Gluconeogenesis and Lipogenesis.长链非编码 RNA lncSHGL 募集 hnRNPA1 以抑制肝脏糖异生和脂生成。
Diabetes. 2018 Apr;67(4):581-593. doi: 10.2337/db17-0799. Epub 2018 Jan 30.
6
Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis.通过胰高血糖素依赖途径,KCTD17介导的PHLPP2降解促进肝脂肪变性。
Gastroenterology. 2017 Dec;153(6):1568-1580.e10. doi: 10.1053/j.gastro.2017.08.039. Epub 2017 Aug 30.
7
Histone H3K9 Demethylase JMJD2B Plays a Role in LXRα-Dependent Lipogenesis.组蛋白 H3K9 去甲基酶 JMJD2B 在 LXRα 依赖性脂肪生成中发挥作用。
Int J Mol Sci. 2020 Nov 5;21(21):8313. doi: 10.3390/ijms21218313.
8
Tcf7l2 in hepatocytes regulates de novo lipogenesis in diet-induced non-alcoholic fatty liver disease in mice.肝细胞中的 Tcf7l2 调控饮食诱导的非酒精性脂肪性肝病小鼠模型中的从头脂肪生成。
Diabetologia. 2023 May;66(5):931-954. doi: 10.1007/s00125-023-05878-8. Epub 2023 Feb 10.
9
Thrombospondin 1 improves hepatic steatosis in diet-induced insulin-resistant mice and is associated with hepatic fat content in humans.血小板反应蛋白 1 可改善饮食诱导的胰岛素抵抗小鼠的肝脂肪变性,并且与人类的肝脂肪含量相关。
EBioMedicine. 2020 Jul;57:102849. doi: 10.1016/j.ebiom.2020.102849. Epub 2020 Jun 21.
10
The brown fat-enriched secreted factor Nrg4 preserves metabolic homeostasis through attenuation of hepatic lipogenesis.富含棕色脂肪的分泌因子Nrg4通过减弱肝脏脂肪生成来维持代谢稳态。
Nat Med. 2014 Dec;20(12):1436-1443. doi: 10.1038/nm.3713. Epub 2014 Nov 17.

引用本文的文献

1
Advances in the Regulation of Lipid Metabolism by Non-Coding RNAs.非编码RNA对脂质代谢调控的研究进展
Animals (Basel). 2025 Sep 7;15(17):2621. doi: 10.3390/ani15172621.
2
Protective effect of exercise on metabolic dysfunction‑associated fatty liver disease: Potential epigenetic mechanisms (Review).运动对代谢功能障碍相关脂肪性肝病的保护作用:潜在的表观遗传机制(综述)
Int J Mol Med. 2025 Oct;56(4). doi: 10.3892/ijmm.2025.5587. Epub 2025 Jul 19.
3
in metabolic-associated fatty liver disease treatment: research progress.代谢相关脂肪性肝病的治疗:研究进展

本文引用的文献

1
Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis.非酒精性脂肪性肝炎的病因、发病机制及治疗
N Engl J Med. 2017 Nov 23;377(21):2063-2072. doi: 10.1056/NEJMra1503519.
2
Hepatic neuregulin 4 signaling defines an endocrine checkpoint for steatosis-to-NASH progression.肝神经调节素 4 信号定义了脂肪变性向 NASH 进展的内分泌检查点。
J Clin Invest. 2017 Dec 1;127(12):4449-4461. doi: 10.1172/JCI96324. Epub 2017 Nov 6.
3
Nonalcoholic Fatty Liver Disease as a Nexus of Metabolic and Hepatic Diseases.非酒精性脂肪性肝病作为代谢和肝脏疾病的纽带。
Front Pharmacol. 2025 Jun 5;16:1565461. doi: 10.3389/fphar.2025.1565461. eCollection 2025.
4
Disrupted minor intron splicing activates reductive carboxylation-mediated lipogenesis to drive metabolic dysfunction-associated steatotic liver disease progression.小内含子剪接破坏会激活还原羧化介导的脂肪生成,从而推动代谢功能障碍相关脂肪性肝病的进展。
J Clin Invest. 2025 Mar 18;135(10). doi: 10.1172/JCI186478. eCollection 2025 May 15.
5
From fatty liver to fibrosis: the impact of miRNAs on NAFLD and NASH.从脂肪肝到肝纤维化:微小RNA对非酒精性脂肪性肝病和非酒精性脂肪性肝炎的影响。
Funct Integr Genomics. 2025 Jan 31;25(1):30. doi: 10.1007/s10142-025-01544-x.
6
Research on the function of epigenetic regulation in the inflammation of non-alcoholic fatty liver disease.非酒精性脂肪性肝病炎症中表观遗传调控功能的研究
Life Med. 2024 Aug 31;3(4):lnae030. doi: 10.1093/lifemedi/lnae030. eCollection 2024 Aug.
7
Zbtb7b defines a compensatory mechanism in MASLD-related HCC progression by suppressing H19-mediated hepatic lipid deposition.Zbtb7b通过抑制H19介导的肝脏脂质沉积,在与代谢相关脂肪性肝病相关的肝癌进展中定义了一种代偿机制。
Physiol Rep. 2024 Dec;12(24):e70160. doi: 10.14814/phy2.70160.
8
Emerging Roles of ncRNAs in Type 2 Diabetes Mellitus: From Mechanisms to Drug Discovery.非编码 RNA 在 2 型糖尿病中的新兴作用:从机制到药物发现。
Biomolecules. 2024 Oct 27;14(11):1364. doi: 10.3390/biom14111364.
9
Transcriptional Regulation of De Novo Lipogenesis by SIX1 in Liver Cancer Cells.肝癌细胞中 SIX1 对从头合成脂肪的转录调控
Adv Sci (Weinh). 2024 Nov;11(41):e2404229. doi: 10.1002/advs.202404229. Epub 2024 Sep 11.
10
Long Noncoding RNAs in Diet-Induced Metabolic Diseases.长链非编码 RNA 在饮食诱导的代谢性疾病中的作用。
Int J Mol Sci. 2024 May 23;25(11):5678. doi: 10.3390/ijms25115678.
Cell Metab. 2018 Jan 9;27(1):22-41. doi: 10.1016/j.cmet.2017.08.002. Epub 2017 Aug 31.
4
Retrospective on Cholesterol Homeostasis: The Central Role of Scap.胆固醇稳态的反思:Scap 的核心作用。
Annu Rev Biochem. 2018 Jun 20;87:783-807. doi: 10.1146/annurev-biochem-062917-011852. Epub 2017 Aug 25.
5
Zbtb7b engages the long noncoding RNA Blnc1 to drive brown and beige fat development and thermogenesis.Zbtb7b 通过结合长链非编码 RNA Blnc1 驱动棕色和米色脂肪的发育和产热。
Proc Natl Acad Sci U S A. 2017 Aug 22;114(34):E7111-E7120. doi: 10.1073/pnas.1703494114. Epub 2017 Aug 7.
6
Conserved function of the long noncoding RNA Blnc1 in brown adipocyte differentiation.长链非编码 RNA Blnc1 在棕色脂肪细胞分化中的保守功能。
Mol Metab. 2016 Nov 3;6(1):101-110. doi: 10.1016/j.molmet.2016.10.010. eCollection 2017 Jan.
7
Mitochondrial Adaptation in Nonalcoholic Fatty Liver Disease: Novel Mechanisms and Treatment Strategies.非酒精性脂肪性肝病中的线粒体适应:新的机制和治疗策略。
Trends Endocrinol Metab. 2017 Apr;28(4):250-260. doi: 10.1016/j.tem.2016.11.006. Epub 2016 Dec 13.
8
Integrative Transcriptome Analyses of Metabolic Responses in Mice Define Pivotal LncRNA Metabolic Regulators.小鼠代谢反应的综合转录组分析确定关键长链非编码RNA代谢调节因子
Cell Metab. 2016 Oct 11;24(4):627-639. doi: 10.1016/j.cmet.2016.08.019. Epub 2016 Sep 22.
9
NAFLD and liver transplantation: Current burden and expected challenges.非酒精性脂肪性肝病与肝移植:当前负担及预期挑战
J Hepatol. 2016 Dec;65(6):1245-1257. doi: 10.1016/j.jhep.2016.07.033. Epub 2016 Jul 30.
10
Feedback modulation of cholesterol metabolism by the lipid-responsive non-coding RNA LeXis.脂质反应性非编码RNA LeXis对胆固醇代谢的反馈调节
Nature. 2016 Jun 2;534(7605):124-8. doi: 10.1038/nature17674. Epub 2016 May 11.